Mydecine Innovations' market value is the price at which a share of Mydecine Innovations trades on a public exchange. It measures the collective expectations of Mydecine Innovations Group investors about its performance. Mydecine Innovations is trading at 0.004 as of the 13th of January 2025. This is a 20 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.004. With this module, you can estimate the performance of a buy and hold strategy of Mydecine Innovations Group and determine expected loss or profit from investing in Mydecine Innovations over a given investment horizon. Check out Mydecine Innovations Correlation, Mydecine Innovations Volatility and Mydecine Innovations Alpha and Beta module to complement your research on Mydecine Innovations.
Please note, there is a significant difference between Mydecine Innovations' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mydecine Innovations is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mydecine Innovations' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mydecine Innovations 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mydecine Innovations' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mydecine Innovations.
0.00
12/14/2024
No Change 0.00
0.0
In 31 days
01/13/2025
0.00
If you would invest 0.00 in Mydecine Innovations on December 14, 2024 and sell it all today you would earn a total of 0.00 from holding Mydecine Innovations Group or generate 0.0% return on investment in Mydecine Innovations over 30 days. Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization o... More
Mydecine Innovations Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mydecine Innovations' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mydecine Innovations Group upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mydecine Innovations' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mydecine Innovations' standard deviation. In reality, there are many statistical measures that can use Mydecine Innovations historical prices to predict the future Mydecine Innovations' volatility.
Mydecine Innovations is out of control given 3 months investment horizon. Mydecine Innovations has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 3.63% are justified by taking the suggested risk. Use Mydecine Innovations Downside Deviation of 30.43, mean deviation of 21.98, and Risk Adjusted Performance of 0.1052 to evaluate company specific risk that cannot be diversified away. Mydecine Innovations holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.95, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Mydecine Innovations are expected to decrease slowly. On the other hand, during market turmoil, Mydecine Innovations is expected to outperform it slightly. Use Mydecine Innovations information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to analyze future returns on Mydecine Innovations.
Auto-correlation
-0.31
Poor reverse predictability
Mydecine Innovations Group has poor reverse predictability. Overlapping area represents the amount of predictability between Mydecine Innovations time series from 14th of December 2024 to 29th of December 2024 and 29th of December 2024 to 13th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mydecine Innovations price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Mydecine Innovations price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.31
Spearman Rank Test
-0.1
Residual Average
0.0
Price Variance
0.0
Mydecine Innovations lagged returns against current returns
Autocorrelation, which is Mydecine Innovations pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mydecine Innovations' pink sheet expected returns. We can calculate the autocorrelation of Mydecine Innovations returns to help us make a trade decision. For example, suppose you find that Mydecine Innovations has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Mydecine Innovations regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mydecine Innovations pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mydecine Innovations pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mydecine Innovations pink sheet over time.
Current vs Lagged Prices
Timeline
Mydecine Innovations Lagged Returns
When evaluating Mydecine Innovations' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mydecine Innovations pink sheet have on its future price. Mydecine Innovations autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mydecine Innovations autocorrelation shows the relationship between Mydecine Innovations pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Mydecine Innovations Group.
Other Information on Investing in Mydecine Pink Sheet
Mydecine Innovations financial ratios help investors to determine whether Mydecine Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mydecine with respect to the benefits of owning Mydecine Innovations security.